; annual reports The Director of the Centers for Disease Control and Prevention shall, each year, update the report entitled Antibiotic Use in the United States to include updated information on progress and opportunities with respect to data, programs, and resources for prescribers to promote appropriate use of antimicrobial drugs. (c) Reports on antifungal resistance and antimicrobial prophylactics Not later than 3 years after the date of enactment of this Act, the Director of the Centers for Disease Control and Prevention shall publish— (1) a report on antifungal resistance in the United States; and (2) a report on antimicrobial prophylactics. 8. Definitions In this Act— (1) the term antimicrobial drug — (A) subject to subparagraph (B), means— (i) an antibiotic drug, as defined in section 201(jj) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(jj) ); or (ii) a biological product, as defined in section 351(i) of the Public Health Service Act ( 42 U.S.C. 262(i) ), that exhibits antimicrobial activity; and (B) excludes— (i) any antifungal drug; and (ii) any vaccine; (2) the term Committee means the Committee on Critical Need Antimicrobials established under section 2; and (3) the term Secretary means the Secretary of Health and Human Services.